Short Communication: High Cellular Iron Levels Are Associated with Increased HIV Infection and Replication
- 1 March 2015
- journal article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 31 (3), 305-312
- https://doi.org/10.1089/aid.2014.0169
Abstract
HIV is a pandemic disease, and many cellular and systemic factors are known to alter its infectivity and replication. Earlier studies had suggested that anemia is common in HIV-infected patients; however, higher iron was also observed in AIDS patients prior to the introduction of antiretroviral therapy (ART). Therefore, the relationship between iron and viral infection is not well delineated. To address this issue, we altered the levels of cellular iron in primary CD4(+) T cells and showed that higher iron is associated with increased HIV infection and replication. In addition, HIV infection alone leads to increased cellular iron, and several ART drugs increase cellular iron independent of HIV infection. Finally, HIV infection is associated with increased serum iron in HIV-positive patients regardless of treatment with ART. These results establish a relationship between iron and HIV infection and suggest that iron homeostasis may be a viable therapeutic target for HIV.Keywords
This publication has 56 references indexed in Scilit:
- Decreased Serum Hepcidin Concentration Correlates with Brain Iron Deposition in Patients with HBV-Related CirrhosisPLOS ONE, 2013
- Role of cellular iron and oxygen in the regulation of HIV-1 infectionFuture Virology, 2013
- Iron status in HIV-1 infection: implications in disease pathologyBMC Clinical Pathology, 2012
- Increased Risk of Severe Infant Anemia After Exposure to Maternal HAART, BotswanaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Hepcidin induces HIV-1 transcription inhibited by ferroportinRetrovirology, 2010
- Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9Molecular Pharmacology, 2010
- Reduced serum hepcidin levels in patients with chronic hepatitis CJournal of Hepatology, 2009
- Tenofovir renal toxicity targets mitochondria of renal proximal tubulesLaboratory Investigation, 2009
- Iron chelators ICL670 and 311 inhibit HIV-1 transcriptionVirology, 2007
- Iron, brain ageing and neurodegenerative disordersNature Reviews Neuroscience, 2004